Source: Virtual Congress 2020 – Covering COVID - the best abstracts



Rating:

Share or cite this content

Citations should be made in the following way:
F. Van De Veerdonk (Nijmegen, Netherlands), M. Looijen-Salamon (Nijmegen, Netherlands), M. Van Den Heuvel (Nijmegen, Netherlands), Q. Van Der Mast (Nijmegen, Netherlands), C. Van Der Meer (Tiel, Netherlands), S. Vos (Nijmegen, Netherlands), S. Van Belle (Nijmegen, Netherlands), S. Vermorgen (Nijmegen, Netherlands), J. Van Der Hoeven (Nijmegen, Netherlands), M. Netea (Nijmegen, Netherlands), K. Grünberg (Nijmegen, Netherlands). Late Breaking Abstract - Plasma cells and endothelitis in COVID-19 lung pathology. 4148

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Organoids and lung-on-chip to study SARS-CoV-2-mediated lung injury Source: Virtual Congress 2020 – Covering COVID - the best abstracts Year: 2020 Late Breaking Abstract - Role of interleukin-10 in normal and aberrant late lung development Source: International Congress 2017 – Postnatal lung growth and development Year: 2017 Late Breaking Abstract - Relationship between obesity and aging of the pulmonary parenchyma Source: Virtual Congress 2020 – New insights into evaluation and treatment of respiratory disease Year: 2020 Late Breaking Abstract - Plasma endocan is over-expressed in AECOPD patients: association with lung function decline and apoptosis Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Late Breaking Abstract - Treatment with ATYR1923 reduces biomarkers in COVID-19 pneumonia Source: Virtual Congress 2021 – Diagnosis and management of COVID-19 Year: 2021 Late Breaking Abstract - Intra-alveolar neutrophil-derived microvesicles: a biomarker of COPD severity Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases Year: 2018 Late Breaking Abstract - Systemic ferritin is an early disease biomarker for silicosis patients Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Late Breaking Abstract - Fully automated airway measurement correlates with radiological disease progression in Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2021 – Remote monitoring of respiratory patients Year: 2021 Late Breaking Abstract - Hypoxia-induced cellular responses in lung fibroblasts from COPD patients and controls Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 Late Breaking Abstract - Association of lung clearance index with survival in patients with cystic fibrosis Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019 Late Breaking Abstract - Aging impairs alveolar epithelial type II cell function in acute lung injury Source: International Congress 2019 – Cellular metabolism and immune senescence in lung pathology Year: 2019 Late Breaking Abstract - Blood and bronchoalveolar neutrophil signatures associate with COPD severity Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases Year: 2021 Late Breaking Abstract - A comprehensive analysis of endothelial cell markers in pulmonary fibrosis Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 Late Breaking Abstract - Roles for transglutaminases in normal and aberrant lung development associated with BPD. Source: International Congress 2017 – Late-breaking findings in pulmonary diseases Year: 2017 Late Breaking Abstract - Rituximab limits the progression of fibrosing mediastinitis Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives Year: 2019 Late Breaking Abstract - Transbronchial lung cryobiopsy for interstitial lung disease diagnosis: results of the COLDICE Study Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Interstitial lung diseases and pulmonary hypertension Year: 2019 Late Breaking Abstract -  Effect of Hypercapnia in human primary culture of alveolar cells in vitro Source: International Congress 2018 – Preclinical and clinical studies of critical illness Year: 2018 Late Breaking Abstract - Characteristics of Post-COVID-19 interstitial lung syndrome in Bronchoalveolar Lavage: Preliminary results. Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases Year: 2021 Late Breaking Abstract - Pathological features of lung lesions in PPFE of idiopathic or transplantation related cases with evaluation of the elastic fiber related conditions comparing to those of IPF/UIP Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019 Late Breaking Abstract - Lung function before and after COVID-19 infection in young adults Source: Virtual Congress 2021 – Respiratory function after COVID-19 and mechanical ventilation Year: 2021